{@shortdesc}

{@title}
{@headline}
Slide: {@currentrow} of {ds_RowCount}  PreviousStopPlayNext

The Drug Safety Executive Council (DSEC) is a peer-to-peer membership of over 1,300 drug safety leaders with the common objective of advancing the development of better and safer medicines.  Learn More.

DSEC is driven by an esteemed Advisory Board of industry executives representing many of the largest and most prominent biopharmaceutical companies in the world.  Regular membership is complimentary and limited to current employees of companies developing small and large molecule pharmaceuticals.
Why Join DSEC?

Regular membership is complimentary
Engage in member-driven discussions, research, and presentations that will help you lead your organization to better decision making
Access live events, on-demand events and a network of peers
Network with other high-level executives at leading biopharmaceutical companies to drive change that will encourage business growth
Membership is limited to leaders representing companies who develop small and large molecule pharmaceuticals

 
 
Featured Events & Content

On-Demand Webinar: FDA Science and Mission at Risk: Implications for Drug Development and Approval
The slides and recording from the May 22 web conference are now available. Click on the title to download both items.

On-Demand Web Sessions

The Truth Behind Drug Safety Decision Making
Held on May 1, 2008.
The Role of Safety Sciences in Defining the Risk Management Program
Held on Feb 14, 2008
Seizing the Opportunities for Government Partnerships to Improve Drug Safety
Featuring Dr. Janet Woodcock, Deputy Commissioner and Chief Medical Officer, FDA. Held July 26, 2007

Executive Summaries: Benchmarking Studies/Reports

The Emergence of High-Content Screening as a Tool for Safety Assessment
Drug safety challenges rank as the leading cause of attrition of compounds in clinical development.